EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Effects of gender‐affirming hormone therapy on lower urinary tract symptoms and sexual function among transgender individuals

Iris Yaish, Hadar Amir, Hila Eilam, Ronen Gold, Asnat Groutz

International Journal of Gynecology & Obstetrics · 2025

DOI: 10.1002/ijgo.15964 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2025. Verfasst von Iris Yaish und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Tel Aviv Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Transgender Persons, Lower Urinary Tract Symptoms, Testosterone, Estrogens. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Gender‐affirming hormone therapy (GAHT) includes estrogen preparations and androgen inhibitors for transgender women, and testosterone preparations for transgender men. The aim of the study was to investigate possible effects of GAHT on lower urinary tract symptoms (LUTS) and sexual function among transgender individuals.

Methods

Fifty‐one transgender men and 47 transgender women were prospectively recruited. Four validated female questionnaires (Bristol Female Lower Urinary Tract Symptoms [BFLUTS] questionnaire, the Medical, Epidemiologic, and Social aspects of Aging [MESA] questionnaire, Urgency, the Severity and Impact Questionnaire [USIQ], and the Female Sexual Function Index [FSFI]) and two validated male questionnaires (International Prostate Symptom Score [IPSS], and the International Index of Erectile Function [IIEF]) were used to assess LUTS and sexual function among transgender men and women, respectively, before and during GAHT. Follow‐up was performed over a period of 3–12 months.

Results

Thirty‐four transgender men (mean age 24.4 ± 7.6 years) and 31 transgender women (mean age 29 ± 8.7 years) completed all questionnaires, before and during GAHT. Testosterone treatment was associated with a statistically significant improvement in sexual desire among transgender men, as reflected in the FSFI questionnaire (4.5 ± 1.2 vs. 3.6 ± 1.3, P = 0.002). None of the three LUTS questionnaires showed statistically significant changes during the treatment with testosterone preparations. Estrogen treatment was associated with a statistically significant decrease in erectile function among transgender women, as reflected by the IIEF questionnaire (9.0 ± 7.2 vs. 14.1 ± 11.1, P = 0.012). No significant changes were found in LUTS during the treatment with estrogen preparations, except for a slight worsening of nocturia (2.1 ± 1.8 vs. 1.1 ± 1.4, P = 0.009).

Conclusions

GAHT was not found to be associated with significant LUTS in both transgender men and women. Nevertheless, some effects on sexual function were observed, mainly a decrease in erectile function among transgender women and an increase in sexual desire among transgender men.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transgender PersonsLower Urinary Tract SymptomsTestosteroneEstrogensSexual Dysfunction, PhysiologicalHumansFemaleMaleAdultSurveys and QuestionnairesProspective StudiesYoung AdultGender-Affirming ProceduresAndrogen AntagonistsMiddle AgedAndrogens

Stichwörter der Autor:innen

gender‐affirming hormone therapylower urinary tract symptomssexual dysfunctiontransgender

Substanzen

TestosteroneEstrogensAndrogen AntagonistsAndrogens

Autor:innen und Institutionen

  • Faculty of Medicine, Tel Aviv Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel.

Zitieren

APA

Yaish, I., Amir, H., Eilam, H., Gold, R., & Groutz, A. (2025). Effects of gender‐affirming hormone therapy on lower urinary tract symptoms and sexual function among transgender individuals. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.15964

Vancouver

Yaish I, Amir H, Eilam H, Gold R, Groutz A. Effects of gender‐affirming hormone therapy on lower urinary tract symptoms and sexual function among transgender individuals. International Journal of Gynecology & Obstetrics. 2025. doi:10.1002/ijgo.15964

BibTeX
@article{Yaish2025,
  author = {Yaish, Iris and Amir, Hadar and Eilam, Hila and Gold, Ronen and Groutz, Asnat},
  title = {Effects of gender‐affirming hormone therapy on lower urinary tract symptoms and sexual function among transgender individuals},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2025},
  doi = {10.1002/ijgo.15964}
}
Kostenlos starten →